Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Rho Associated Protein Kinase 2 - Pipeline Review, H2 2019
US$ 3,500.00
Rho Associated Protein Kinase 2 - Pipeline Review, H2 2019 SUMMARY Rho Associated Protein Kinase 2 (Rho Kinase 2 or Rho Associated Coiled Coil Containing Protein Kinase 2 or p164 ROCK 2 or ROCK2 or...
December 2019
64 pages
Somatostatin Receptor Type 2 - Pipeline Review, H2 2019
US$ 3,500.00
Somatostatin Receptor Type 2 - Pipeline Review, H2 2019 SUMMARY Somatostatin Receptor Type 2 (SRIF1 or SSTR2) pipeline Target constitutes close to 13 molecules. The latest report Somatostatin Recept...
December 2019
71 pages
Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019
US$ 3,500.00
Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019 SUMMARY Stromal Cell Derived Factor 1 (C-X-C Motif Chemokine 12 or Intercrine Reduced In Hepatomas or SDF1 or Pre B Cell Growth Stimulating F...
December 2019
66 pages
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H2 2019
US$ 3,500.00
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H2 2019 SUMMARY Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) pipeline Target con...
December 2019
79 pages
TGF Beta Receptor Type 1 - Pipeline Review, H2 2019
US$ 3,500.00
TGF Beta Receptor Type 1 - Pipeline Review, H2 2019 SUMMARY TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Pro...
December 2019
71 pages
Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019
US$ 3,500.00
Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'Tryptophan 2,3 Dioxygenase - Pipeline Review, H2 2019'; Tryptophan 2,3 Dioxygenase (Tryptami...
December 2019
40 pages
Tyrosine Protein Kinase CSK - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase CSK - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Tyrosine-protein kinase CSK also know...
December 2019
85 pages
Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) pipeline T...
December 2019
103 pages
Tyrosine Protein Kinase ITKTSK - Pipeline Review, H2 2019
US$ 3,500.00
Tyrosine Protein Kinase ITKTSK - Pipeline Review, H2 2019 SUMMARY Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein K...
December 2019
66 pages
Muscle Spasticity - Pipeline Review, H2 2019
US$ 2,000.00
Muscle Spasticity - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscle Spasticity - Pipeline Review, H2 2019, provides an ove...
December 2019
110 pages
Postoperative Ileus - Pipeline Review, H2 2019
US$ 2,000.00
Postoperative Ileus - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Postoperative Ileus - Pipeline Review, H2 2019, provides an...
December 2019
40 pages
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2019
US$ 2,500.00
... Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
2792 pages
Neuropathic Pain - Pipeline Review, H2 2019
US$ 2,500.00
... . The Neuropathic Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuropathic Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
838 pages
Peptic Ulcers - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Peptic Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peptic Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
66 pages
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2019
US$ 2,000.00
... Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
615 pages
Female Sexual Dysfunction - Pipeline Review, H2 2019
US$ 2,000.00
... . The Female Sexual Dysfunction (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Sexual Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
83 pages
Premenstrual Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Premenstrual Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premenstrual Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
37 pages
Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2019
US$ 2,500.00
... releases. The Multiple Myeloma (Kahler Disease) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Multiple Myeloma (Kahler Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
2062 pages
Myelodysplastic Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myelodysplastic Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Myelodysplastic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
1542 pages
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2019
US$ 2,500.00
... Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
1463 pages
Enterocolitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Enterocolitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Enterocolitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
December 2019
54 pages
Toxoplasmosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Toxoplasmosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Toxoplasmosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
45 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Cervical Intraepithelial Neoplasia (CIN) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Cervical Intraepithelial Neoplasia (CIN) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
133 pages
Canavan Disease - Pipeline Review, H2 2019
US$ 2,000.00
... . The Canavan Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Canavan Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
36 pages
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Metachromatic Leukodystrophy (MLD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
December 2019
69 pages
Short Bowel Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Short Bowel Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Short Bowel Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
67 pages
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Failure (Hepatic Insufficiency) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
98 pages
Dengue Fever - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Dengue Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Dengue Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
173 pages
Meningitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Meningitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Meningitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
67 pages
Poliomyelitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Poliomyelitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Poliomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
88 pages
Female Contraception - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Female Contraception (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
December 2019
102 pages
